Company Description
Barr Pharmaceuticals is raising the bar and lowering the prices for many medications. The company is one of the world's largest makers of generic...
Key Barr Pharmaceuticals Financials
| Company Type | Public - NYSE: BRL Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $2,500.6 |
| 2007 Employees | 8,900 |
More Barr Pharmaceuticals Financials (11 pages)
Latest Barr Pharmaceuticals Jobs jobs by Indeed
Rankings
- S&P 500
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Barr Pharmaceuticals's competition across multiple industries
Top Barr Pharmaceuticals Competitors
Sponsored Links
The Business Directory
Barr Pharmaceuticals Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Bruce L. Downey | Network | E-mail |
| EVP, CFO, and Treasurer | William T. (Bill) McKee | Network | E-mail |
| EVP Global Strategic Planning | Christopher Mengler | Network | E-mail |
More Barr Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Barr Pharmaceuticals News
- Merrill Lynch sees Barr solidifying Teva's 2009-10 growth: Merrill Lynch today reiterated its "Buy" recommendation and $54 price target for Teva. [Globes (Tel Aviv)] (02 Oct 2008 04:00:00 EDT)
- CONJUGATED ESTROGEN COMPOSITIONS, APPLICATORS, KITS, AND METHODS OF MAKING AND USE THEREOF [European Patents] (29 Sep 2008 11:46:00 EDT)
- Treatment of conditions relating to hormone deficiencies by administration of progestins [U.S. Patents] (29 Sep 2008 11:33:00 EDT)
Sponsored Opportunity
